孕早期使用苯二氮卓类药物并未增加重大先天缺陷的风险
Benzodiazepine use in first trimester not associated with higher risk for major birth defects
一项发表在《内科年鉴》上的基于人群的队列研究显示,在孕早期使用苯二氮卓类药物的孕妇与未使用的孕妇相比,后代发生重大先天缺陷的风险并未显著增加。研究团队分析了2000年至2020年间420万份Medicaid和商业保险记录,其中7.9万例孕早期填写过至少一次苯二氮卓类药物处方。
基于420万孕次的大样本观察性研究,为孕期使用苯二氮卓类药物的安全性提供了新的循证参考。
A population-based cohort study found that pregnant people who used benzodiazepines during the first trimester were not at a substantially increased risk of having a baby with major birth defects. The rates of overall major congenital malformations were comparable between pregnancies exposed to benzodiazepines and those that were not, providing reassuring evidence about the safety of these medications in early pregnancy. The study is published in Annals of Internal Medicine.
Researchers from Brigham and Women's Hospital and Harvard Medical School and colleagues analyzed data from a cohort of 4.2 million Medicaid and commercially insured pregnancies between 2000 and 2020 to assess the risk of major congenital malformations from first-trimester exposure to benzodiazepines. They compared outcomes among 79,000 people who filled at least one benzodiazepine prescription in early pregnancy with those who did not.
The investigators found no meaningful increase in the risk of overall major birth defects and no consistent evidence of organ-specific malformations previously thought to be associated with benzodiazepine exposure.
While the authors concluded that first-trimester benzodiazepine exposure was not associated with a meaningful increase in birth defect risk, they note that the safety of benzodiazepine use during pregnancy warrants further research to continue monitoring rare birth defects and longer exposures and to examine other pregnancy outcomes.
Publication details
Benzodiazepine Use Early in Pregnancy and Risk for Congenital Malformations, Annals of Internal Medicine (2026). DOI: 10.7326/ANNALS-25-05148
Journal information: Annals of Internal Medicine
Key medical concepts
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Benzodiazepine use in first trimester not associated with higher risk for major birth defects (2026, October 12) retrieved 12 October 2026 from https://medicalxpress.com/news/2026-10-benzodiazepine-trimester-higher-major-birth.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com